Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR
DIWClass II

Hemagglutination Inhibition, Methadone

21 CFR 862.3620 / Clinical Toxicology

DIW is the FDA product code for Hemagglutination Inhibition, Methadone, a class II device type, regulated under 21 CFR 862.3620. As of , FDA records hold 4 510(k) clearances under this code, the most recent dated , and no recalls.

Classification record

Product code
DIW
Device name
Hemagglutination Inhibition, Methadone
Regulation
21 CFR 862.3620
Device class
Class II
Review panel
Clinical Toxicology
Submission type
510(k)
Implant
No
Life sustaining or supporting
No
GMP exempt
No
Third party review eligible
Yes
Ingested clearances
4
Ingested recalls
0

Clearances, product code DIW

By decision year
4 clearances under product code DIW with a decision year between 1976 and 1995, 1976 the highest year at 1.
Show the numbers
510(k) clearances under FDA product code DIW by decision year
YearClearances
19761
19801
19931
19951

Applicants with the most clearances

Product code DIW
Applicants holding the most 510(k) clearances under product code DIW
ApplicantClearances
E.I. Dupont de Nemours & Co., Inc.1
J.T. Baker Chemical Co.1
Roche Diagnostic Systems, Inc.1
Technam, Inc.1

Companies listing this code with FDA

Companies whose registered establishments list this code

No registered establishment in MDM’s records lists product code DIW.